{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:28:07Z","timestamp":1793550487833,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.xpro.2026.104897","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:56:47Z","timestamp":1791655007000},"page":"104897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protocol for an immunocompetent KPC mouse model of pancreatic cancer resection and recurrence for perioperative treatment studies"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7082-9781","authenticated-orcid":false,"given":"Jacob L.","family":"L\u00e9ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal","family":"Amhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0034-8088","authenticated-orcid":false,"given":"Sarah","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6360-9794","authenticated-orcid":false,"given":"Maria Fernanda Meza","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0847-4369","authenticated-orcid":false,"given":"Lauren","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7193-0051","authenticated-orcid":false,"given":"Hugo","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1176-4941","authenticated-orcid":false,"given":"Lee-Hwa","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2026.104897_bib1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2026.104897_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xpro.2026.104897_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000521631","article-title":"Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling","volume":"38","author":"Ettrich","year":"2022","journal-title":"Visc. Med."},{"key":"10.1016\/j.xpro.2026.104897_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hpb.2020.01.005","article-title":"Recurrence patterns of pancreatic cancer after pancreatoduodenectomy: systematic review and a single-centre retrospective study","volume":"22","author":"Kalisvaart","year":"2020","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.xpro.2026.104897_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.surge.2010.07.011","article-title":"Surgery induced immunosuppression","volume":"9","author":"Hogan","year":"2011","journal-title":"Surgeon"},{"key":"10.1016\/j.xpro.2026.104897_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1071751","article-title":"Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma","volume":"13","author":"Mansouri","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xpro.2026.104897_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0b013e31826fcbdb","article-title":"Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine model","volume":"258","author":"Seth","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.xpro.2026.104897_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.21037\/hbsn-2025-96","article-title":"Recurrence after neoadjuvant therapy for pancreatic cancer: same challenges, new opportunities","volume":"14","author":"Neilson","year":"2025","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.xpro.2026.104897_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.104337","article-title":"Protocol for orthotopic implantation of a collagen hydrogel to model pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Agolia","year":"2026","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xpro.2026.104897_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4174\/astr.2025.108.5.317","article-title":"Establishment of an orthotopic nude mouse model for recurrent pancreatic cancer after complete resection: an experimental animal study","volume":"108","author":"Park","year":"2025","journal-title":"Ann. Surg. Treat. Res."},{"key":"10.1016\/j.xpro.2026.104897_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11605-020-04681-9","article-title":"An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence","volume":"25","author":"Giri","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.xpro.2026.104897_bib12","first-page":"385","article-title":"Effect of splenectomy on antitumor immune system in mice","volume":"29","author":"Higashijima","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.xpro.2026.104897_bib13","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/s41598-024-54768-5","article-title":"Splenectomy has opposite effects on the growth of primary compared with metastatic tumors in a murine colon cancer model","volume":"14","author":"Kaneko","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xpro.2026.104897_bib14","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-22-3645","article-title":"Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma","volume":"83","author":"Rohila","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.xpro.2026.104897_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424409122","article-title":"CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity","volume":"122","author":"Rodriguez","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xpro.2026.104897_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","article-title":"CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer","volume":"11","author":"Jacoberger-Foissac","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xpro.2026.104897_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejca.2021.10.023","article-title":"Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials","volume":"160","author":"van Dam","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xpro.2026.104897_bib18","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S1470-2045(25)00363-8","article-title":"Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial","volume":"26","author":"Janssen","year":"2025","journal-title":"Lancet Oncol."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726005502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726005502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:43:40Z","timestamp":1793547820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166726005502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2666166726005502"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104897","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for an immunocompetent KPC mouse model of pancreatic cancer resection and recurrence for perioperative treatment studies","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104897"}}